semaglutide weight loss liver transplant recipients A study from the New England Journal of Medicine found new evidence that GLP-1 drugs, like Ozempic and Wegovy, used for diabetes and obesity could also help people with a type of disease. CBS Key challenges of post-liver transplant

377 Iron overload, following increased intake, which may in particular result from the use of iron-containing implants widely employed in orthopaedic surgery, 378 or can occur after haemorrhagic stroke, results in compensatory upregulation of glial iron transporters, and down-regulation of neuronal iron transporters, both aimed at neuroprotection

H.Sonuga-BarkeE

Late, but Not Early, Night Sleep Loss Compromises Neuroendocrine Appetite Regulation and the Desire for Food

3 A novel approach involving dermal infusion of these medications via scalp tattooing has demonstrated both safety and efficacy as a therapeutic option

#DiabetesCure #Type1Diabetes #GeneEditing #CRISPR #InsulinProduction #MedicalBreakthrough #HealthcareInnovation #FunctionalCure #RegenerativeMedicine #PrecisionMedicine #BiotechNews #LifeSciences #MedicalResearch #ScienceNews #FutureOfMedicine #ChronicIllness #EndType1Diabetes #HopeForMillions To view or add a comment, sign in Emerging research suggests that certain GLP-1 therapies may lower heart attack risk even when weight loss is minimal